Today we will discuss various kinds of immune responses observed in COVID-19 patients. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
More lectures on DrBeen.com Looking to support my work? Donate here: Dr. Paul is the Chief of Pulmonary and Critical Care Medicine Eastern Virginia Medical School, Norfolk, VA MATH+ Protocol has been saving lives in Dr. Marik’s ICU in Norfolk…
Dr. Salman Tahir – Labs Continuing to discuss Dr. Salman Tahir’s case (RIP.) Today we will discuss the labs. p.s. please avoid commenting to offer what could have been done differently. His family’s point of view is to offer this…
Glenmark’s FabiFlu approved for coronavirus treatment in India, costs Rs 103 per tablet Mumbai-based Glenmark Pharmaceuticals have launched a new antiviral drug – Favipiravir with brand name FabiFlu – for the treatment of mild to moderate Covid-19 patients. The firm…
COVID-19 Insights. An Invitro VIRAL BLOCKER Camostat Mesylate Links to the news Acute MI incidence was reduced during the lockdown. It is increasing again after the lockdown is lifted. Infection can spread by aerosol CDC thinks that the infection is…
A preliminary study has found tentative evidence suggesting low levels of vitamin D may make it more likely an individual will die after contracting coronavirus. The research compared average levels of vitamin D across 20 European countries with Covid-19 infection…
